文献速递临床试验与 GCP

新型含锌脱敏剂CAREDYNE Shield治疗牙本质敏感症疗效的初步随机对照试验研究方案

The efficacy of the novel zinc-containing desensitizer CAREDYNE Shield on dentin hypersensitivity: a study protocol for a pilot randomized controlled trial.
PubMed 文献 · Trials · 2020-06-03

本研究为双臂平行初步随机对照试验,计划纳入40例牙本质敏感症患者,随机分配至CAREDYNE Shield组或Nanoseal组。主要结局为干预后4周空气刺激疼痛强度较基线的降低,采用5点口头反应量表测量,使用Fisher精确检验分析。研究旨在评估CAREDYNE Shield对牙本质敏感症的临床有效性。

要点

  • CAREDYNE Shield通过化学封闭牙本质小管并释放锌离子发挥作用。
  • 主要结局为干预后4周空气刺激疼痛强度较基线的降低。
  • 试验计划纳入40例牙本质敏感症患者,随机分为两组。

核心结论

  • CAREDYNE Shield对牙本质敏感症的临床有效性尚不明确,需通过本试验评估。

研究设计与样本

  • 研究方案为双臂平行初步随机对照试验,计划纳入40例牙本质敏感症患者。
  • 干预组使用CAREDYNE Shield,对照组使用日本常用的脱敏剂Nanoseal。

关键数值与推荐

  • 主要结局为干预后4周空气刺激疼痛强度较基线的降低,采用5点口头反应量表测量,使用Fisher精确检验分析。
  • 试验注册号为UMIN000038072,于2019年9月21日注册。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dentin hypersensitivity (DH) is a condition characterized by short and sharp episodes of pain which will arise in response to tactile, chemical, thermal, evaporative or osmotic stimuli. The painful symptoms cause discomfort in patients and reduce their quality of life. Recently, the novel zinc-containing desensitizer CAREDYNE Shield has been developed as a new type of desensitizer that acts by inducing chemical occlusion of dentinal tubules, and releasing zinc ion for root caries prevention. However, the clinical effectiveness of CAREDYNE Shield on DH remains unclear. Therefore, the aim of this study is to evaluate the effectiveness of CAREDYNE Shield on DH by comparing with that of another desensitizer, Nanoseal, commonly used in Japan. METHODS/DESIGN: This study protocol is a two-arm, parallel, pilot randomized controlled trial. Forty DH patients will be randomly allocated to two groups. Participants in the intervention group will be treated with CAREDYNE Shield, while those in the control group will be treated with Nanoseal. The primary outcome is the reduction of pain intensity in response to air stimuli measured with a 5-point verbal response scale from baseline to 4 weeks after the intervention, and Fisher's exact test will be used for analyses. DISCUSSION: CAREDYNE Shield can be casually applied to subgingival areas and proximal surfaces because it reacts with only tooth substance. Furthermore, zinc has been reported to reduce the demineralization of enamel and dentin and inhibit biofilm formation, plaque growth and dentin-collagen degradation. Therefore, CAREDYNE Shield may be expected to be a useful novel desensitizer that acts not only as a desensitizer but also as a root caries inhibitor. TRIAL REGISTRATION: UMIN Clinical Trials Registry (UMIN-CTR), ID: UMIN000038072. Registered on 21 September 2019. TRIAL STATUS: This study (protocol version number: version 1.4.0; approved on 22 October 2019) is ongoing. The recruitment of participants began in December 2019 and will be continued until November 2020 (Hanke, Am Dent Assoc 27:1379-1393, 1940).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Matsuura T, Mae M, Ohira M, et al. The efficacy of the novel zinc-containing desensitizer CAREDYNE Shield on dentin hypersensitivity: a study protocol for a pilot randomized controlled trial. Trials. 2020. PMID: 32493500. doi:10.1186/s13063-020-04426-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。